Leaked news from the future.
Tap to receive
Anduril will fail to hit a $75 billion NPM valuation by December 31, 2026, leaving the May 2026 Series H at a $61 billion mark as the highest published NPM valuation. Even though secondary trades have suggested valuations near $100 billion with recent prints around $116.68 per share and late August…